MOBIX LABS, INC (MOBX) Form 424B3 — Nov 16, 2026
Mobix Labs filed Prospectus Supplement No. 1 to its S-1, incorporating an 8-K that discloses three major developments: termination of its merger agreement with Special Project Delivery after the parties could not obtain a fairness opinion, board approval of a 1-for-7 reverse stock split effective November 16, 2026, and preliminary Q4 results showing a sharp turnaround. The 1-for-7 reverse split reduces outstanding Class A shares from approximately 23.6 million to approximately 3.4 million and is explicitly intended to maintain compliance with Nasdaq's minimum bid price requirement, with the stock closing at just $0.51 on November 13.
Key figures
- Eps
- 0
- Revenue
- 1810000
- Revenue Yoy
- -4% (Q4 preliminary)
- Shares Outstanding
- approximately 3,378,082 post-split (from approximately 23,646,570)
- Fy2026 net loss
- 41860000
- Accounts payable
- 4880000
- Fy2026 stock comp
- 12300000
- Total liabilities
- 29630000
- Product revenue q4
- 1430000
- Reverse split ratio
- 1:7
- Stockholders equity
- 4870000
- Closing price nov 13
- 0.51
- Gaap gross margin q4
- 44.5%
- Gaap gross profit q4
- 804000
- Gaap operating loss q4
- 6560000
- Preceding quarter revenue
- 789000
- Gaap net loss prior quarter
- 16800000
- Shares covered by prospectus
- 6000000
- Gaap gross margin prior quarter
- 12.9%
- Product revenue growth sequential
- 171%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.